When it comes to identifying stocks that might make useful investments, there are as many strategies as there are people. You can break these strategies into any different number of categories. I like to differentiate between strategies by thinking first about the amount of time I might actually plan to hold the stock in question; […]
Read MorePlus, House Democrats unveiled their latest coronavirus relief bill, Sanofi said the U.S. will get its COVID-19 vaccine before the rest of the world if successful, JCPenney is talking with lenders ahead of an expected bankruptcy filing, and Tesla won its battle to start reopening its Fremont, CA plant.
Read MoreTrade Setup Buy Target $4.31 Sell Target $5.36 Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development […]
Read MoreBuy Price: $3.80 or better Sell Price: TradersPro Sell Signal Harmony Gold Mining Company Limited engages in the exploration, extraction, and processing of gold. The company also explores for uranium, silver, and copper deposits. It has nine underground operations; an open-pit mine; and various surface treatment operations in South Africa.
Read MoreAs economies throughout the world begin to reopen on a gradual basis, economic reports are starting to come in reflecting the very real, and very dramatic impact that COVID-19 and global shutdowns have had on corporate operations. While that impact is very surprising at all, I do think that as investors look for constructive places […]
Read MorePlus, the Trump Administration is facing renewed pressure to provide more economic stimulus, the consumer price index fell by the most on record in April, and Tesla reopened its Fremont, CA plant against local county orders.
Read MoreTrade Setup Buy Target $2.03 Sell Target $3.60 Gannett Co., Inc. operates as a media and marketing solutions company in the United States. It operates in Publishing and Marketing Solutions segments. The company’s principal products include 261 daily newspapers with total paid circulation of approximately 2.5 million and Sunday circulation of 3.3 million.
Read MoreBuy Price: $3.00 or better Sell Price: TradersPro Sell Signal Eastman Kodak Company provides hardware, software, consumables, and services to customers in the graphic arts, commercial print, publishing, electronic displays, entertainment and commercial films, and consumer products markets worldwide. The company operates in six segments: Print Systems, Enterprise Inkjet Systems, Software and Solutions, Consumer and […]
Read MorePlus, the FDA granted emergency use authorization for Abbott Laboratories’ COVID-19 antibodies test, oil is higher after Saudi Arabia said it would cut production by an additional 1 million barrels per day, and Constellation Brands got a downgrade from MKM Partners.
Read MoreHaving a contrarian temperament generally means doing the opposite of what most people would do. It’s a mindset that I’ve found very useful as an investor, because while most people tend to flock to stocks that are at or near all-time highs, I’m able to find excellent long-term opportunities at much lower, bargain-level prices. It’s […]
Read MoreTrade Setup Buy Target $5.79 Sell Target $7.14 Five Point Holdings, LLC, through its subsidiary, Five Point Operating Company, LP, plans, develops, and owns mixed-use communities in California, the United States. The company operates through four segments: Newhall, San Francisco, Great Park, and Commercial.
Read MoreTrade Setup Buy Target $7.32 Sell Target $9.63 Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis.
Read MoreOver the last month and a half, the market has rebounded pretty strongly off of its bear market lows. Just as the slide that started in February as nations across the globe began imposing economic shutdowns and shelter-in-place orders to slow the COVID-19 infection rate affected just about every sector of the economy, so to […]
Read MoreBuy Price: $14.75 or better Sell Price: TradersPro Sell Signal Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies using protein design technology. The company’s lead product candidate is NL-201, a computationally-designed de novo protein therapeutic for the treatment of IL-2/IL-15 cancer immunotherapy. It also engages in research activities for the treatment of autoimmunity and allergy.
Read MorePlus, Sorrento Therapeutics is partnering with New York’s Mount Sinai on developing a antibody cocktail to shield health care workers and other front-line workers from the coronavirus, Tesla is resuming production at its Fremont, CA plant, and Disney shares got a boost from tickets selling out within minutes for the reopening of its Shanghai Disneyland park.
Read More